PMID- 18514383 OWN - NLM STAT- MEDLINE DCOM- 20090115 LR - 20090714 IS - 0302-2838 (Print) IS - 0302-2838 (Linking) VI - 54 IP - 4 DP - 2008 Oct TI - Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. PG - 794-802 LID - 10.1016/j.eururo.2008.05.018 [doi] AB - BACKGROUND: Previous trials have shown that the number of procedures done by a single surgeon, that is, surgical volume (SV), is associated with several outcomes after radical prostatectomy (RP). OBJECTIVE: To test the association between SV and the detection of lymph node metastases during extended pelvic lymph node dissection (ePLND). DESIGN, SETTING, AND PARTICIPANTS: The study cohort consisted of 1020 men surgically treated for clinically localized prostate cancer. INTERVENTION: All patients underwent RP and ePLND by a group of six surgeons who were trained by the surgeon with the highest SV. All surgeons performed an anatomically extended PLND, including removal of obturator, external iliac, and hypogastric nodes. MEASUREMENTS: Univariable and multivariable logistic regression models tested the association between SV (either continuously coded or dichotomized according to the most informative cut-off, namely >144 vs < or =144 ePLNDs) and the rate of lymph node invasion (LNI) after accounting for preoperative (baseline prostate-specific antigen [PSA], clinical stage, biopsy Gleason sum) and postoperative (pathologic stages and Gleason score, surgical margin status) patient characteristics. RESULTS AND LIMITATIONS: Mean number of nodes removed was 19.1 (median, 16; range, 7-63). Mean overall SV was 227 (range, 87-379). Overall, LNI rate was 11.8% (120/1020). No significant differences were found among patients treated by the different surgeons in terms of clinical and pathologic characteristics (all p> or =0.06). Conversely, the surgeon with the highest SV removed more nodes and found more nodal metastases compared with the other surgeons (21.1 vs 17.9 mean number of nodes removed; p<0.001, and 15 vs 9.8% of LNI; p=0.01, respectively). At univariable logistic regression analysis, either continuously coded or dichotomized SV was a significant predictor of LNI (p=0.007 and p<0.001, respectively). In multivariable models, continuously coded as well as dichotomized SV maintained a significant association with the rate of LNI, after accounting for preoperative (p=0.04 and p=0.009, respectively) as well as for postoperative variables (p=0.03 and p=0.002, respectively). CONCLUSIONS: After adjusting for clinical and pathologic case-mix differences, patients treated by the highest-volume surgeons (>144 ePLNDs) were more likely to have LNI than those treated by low-volume surgeons, even though all surgeons used a similar extended template for node removal. FAU - Briganti, Alberto AU - Briganti A AD - Department of Urology, Vita-Salute University, Milan, Italy. briganti_alberto@yahoo.it FAU - Capitanio, Umberto AU - Capitanio U FAU - Chun, Felix K-H AU - Chun FK FAU - Gallina, Andrea AU - Gallina A FAU - Suardi, Nazareno AU - Suardi N FAU - Salonia, Andrea AU - Salonia A FAU - Da Pozzo, Luigi F AU - Da Pozzo LF FAU - Colombo, Renzo AU - Colombo R FAU - Di Girolamo, Valerio AU - Di Girolamo V FAU - Bertini, Roberto AU - Bertini R FAU - Guazzoni, Giorgio AU - Guazzoni G FAU - Karakiewicz, Pierre I AU - Karakiewicz PI FAU - Montorsi, Francesco AU - Montorsi F FAU - Rigatti, Patrizio AU - Rigatti P LA - eng PT - Journal Article DEP - 20080521 PL - Switzerland TA - Eur Urol JT - European urology JID - 7512719 SB - IM CIN - Eur Urol. 2008 Oct;54(4):803-4. PMID: 18514382 CIN - Eur Urol. 2008 Oct;54(4):802-3. PMID: 18514384 CIN - Eur Urol. 2008 Oct;54(4):955-6. PMID: 18687518 CIN - Eur Urol. 2009 Feb;55(2):e32-3; author reply e34-5. PMID: 18760527 MH - Adult MH - Aged MH - Aged, 80 and over MH - Humans MH - *Lymph Node Excision MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Organ Size MH - Prospective Studies MH - *Prostatectomy MH - Prostatic Neoplasms/*pathology/*surgery EDAT- 2008/06/03 09:00 MHDA- 2009/01/16 09:00 CRDT- 2008/06/03 09:00 PHST- 2008/01/01 00:00 [received] PHST- 2008/05/07 00:00 [accepted] PHST- 2008/06/03 09:00 [pubmed] PHST- 2009/01/16 09:00 [medline] PHST- 2008/06/03 09:00 [entrez] AID - S0302-2838(08)00623-4 [pii] AID - 10.1016/j.eururo.2008.05.018 [doi] PST - ppublish SO - Eur Urol. 2008 Oct;54(4):794-802. doi: 10.1016/j.eururo.2008.05.018. Epub 2008 May 21.